Kathryn Strobel Kwant

Kathryn Strobel Kwant has extensive work experience in the biotechnology and healthcare industries. Kathryn is currently a Co-Founder at Engage Bio since February 2022. Prior to that, they worked at Harpoon Therapeutics where they held various roles including Associate Director from January to February 2022, Senior Scientist from January 2019 to December 2021, and Scientist from May 2017 to December 2018. Before joining Harpoon Therapeutics, they worked as a Development Scientist at Bayer HealthCare from August 2015 to May 2017. Kathryn started their career as a PhD Candidate at UC Berkeley from August 2010 to July 2015.

Kathryn Strobel Kwant holds a Ph.D. in Chemical and Biomolecular Engineering from the University of California, Berkeley. Kathryn also obtained their B.S. in Chemical Engineering from the University of Virginia.